Endocardial versus whole-myocardial tracking global longitudinal strain analysis in patients with hypertrophic

Jiesuck Park1,2, Yeonyee E Yoon1,2, Eun Ju Chun3,4

  • 1Department of Cardiology, Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Republic of Korea.

Plos One
|July 11, 2023
PubMed

Insights

Global longitudinal strain (GLS) assessed by transthoracic echocardiography is feasible in hypertrophic cardiomyopathy (HCM). Whole myocardial tracking GLS is superior to endocardial tracking GLS in patients with severe HCM and significant hypertrophy.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Echocardiography

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
  • Assessing left ventricular (LV) function is crucial for managing HCM.
  • Global longitudinal strain (GLS) is an important metric for LV function.

Purpose of the Study:

  • To compare the feasibility and diagnostic performance of LV GLS using endocardial versus whole myocardial tracking techniques in HCM patients.
  • To investigate the association of GLS with late gadolinium enhancement (LGE) extent in HCM.
  • To determine which GLS methodology is more effective in identifying extensive LGE.

Main Methods:

  • Retrospective analysis of 111 HCM patients undergoing transthoracic echocardiography (TTE) and cardiac magnetic resonance imaging.
  • Measurement of TTE-derived GLS using both whole myocardial and endocardial tracking techniques.
  • Comparison of GLS parameters with LGE extent and discrimination performance for extensive LGE (>15% LV myocardium).

Main Results:

  • Both TTE-whole myocardial and TTE-endocardial GLS were feasible and correlated with LGE extent.
  • Absolute endocardial GLS values were higher than whole myocardial GLS values.
  • In patients with severe hypertrophy (LV mass index >70 g/m2), whole myocardial GLS showed significant correlation and independent association with extensive LGE, unlike endocardial GLS.

Conclusions:

  • TTE-derived GLS is feasible in HCM patients using either endocardial or whole myocardial tracking.
  • Whole myocardial GLS is a more reliable indicator of LGE extent in HCM patients with severe hypertrophy compared to endocardial GLS.
Abstract